P15-10. Preventive HIV vaccine acceptability and behavioral risk compensation among high-risk men who have sex with men and transgenders in Thailand
Bibliographic record
Abstract
Thailand, site of numerous HIV chemoprophylaxis trials and the world's only ongoing phase-3 HIV vaccine trial, may be an early adopter of HIV vaccines. We assessed acceptability of preventive HIV vaccines and behavioral risk compensation among individuals from high-risk communities likely to be targeted for initial vaccine roll-out. We developed a structured questionnaire based on our formative qualitative research (n = 30) among vulnerable community stakeholders, HIV physicians and HIV prevention experts in Thailand. The 30-minute questionnaire was programmed on laptop computers in Thai and administered by trained interviewers. Participants were recruited using venue-based sampling from sex venues and community-based organizations serving men who have sex with men (MSM), male sex workers and transgenders in Bangkok and Chiang Mai. We assessed HIV vaccine acceptability using conjoint analysis and a fractional factorial experimental design, and risk behavior intentions in response to HIV vaccine uptake. Participants (n = 260) were MSM (84.2%) and transgenders (15.8%); mean age = 26.7 (SD = 5.6) years. Most (58.1%) engaged in paid sex; 20.0% reported STI diagnosis (past year); with an average of 11.3 male partners (past 3 months). HIV vaccine acceptability ranged from 73.8 (SD = 29.6) to 31.9 (SD = 33.6) on a 100-point scale; mean = 58.5 (SD = 17.3). Vaccine-induced seropositivity (VISP) had the greatest impact on acceptability (18.5; p < 0.001), followed by efficacy (15.7; p < 0.001), side effects (9.4; p < 0.001), duration (5.0; p < 0.001), out-of-pocket cost (3.6; p = 0.005) and social saturation (i.e., percentage of the population already vaccinated; 2.5; p = 0.02). Over one-third (34.6%) reported intentions to increase sexual risk behaviors in response to HIV vaccine uptake. Findings support the development of interventions to mitigate the impact of VISP, increase acceptability of partially efficacious vaccines and foster understanding about possible side effects, which may facilitate HIV vaccine uptake among high-risk MSM and transgenders in Thailand. Behavioral interventions to decrease risk compensation will be a crucial component of combination prevention.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame distilled prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.
Codex and Gemma teacher scores by category
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.000 | 0.000 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.000 | 0.000 |
| Bibliometrics | 0.000 | 0.000 |
| Science and technology studies | 0.000 | 0.000 |
| Scholarly communication | 0.000 | 0.000 |
| Open science | 0.000 | 0.000 |
| Research integrity | 0.000 | 0.000 |
| Insufficient payload (model declined to judge) | 0.001 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one teacher head, not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".